Sidney Kimmel Cancer Center at Jefferson | Strategic Alliance Partners

April 11, 2017

Leonard Gomella, MD, professor, chair, Department of Urology, director, Kimmel Cancer Center Network, Thomas Jefferson University Hospital, discusses immunotherapy in bladder cancer.

April 05, 2017

Adam Dicker, MD, PhD, professor, chair, department of Radiation Oncology Sidney Kimmel Cancer Center, Thomas Jefferson University, discusses the impact of genetic testing for patients with prostate cancer.

March 10, 2017

Leonard Gomella, MD, professor, chair, Department of Urology, director, Kimmel Cancer Center Network, Thomas Jefferson University Hospital, discusses challenges facing genetic testing for patients with prostate cancer.

March 07, 2017

Scientists at the Sidney Kimmel Cancer Center at Thomas Jefferson University have developed a non-invasive technique to detect the presence of prostate cancer cells in patients' urine.

March 07, 2017

Researchers at the Sidney Kimmel Cancer Center at Thomas Jefferson University discover that isomiRs (small non-coding RNA molecules produced in a cell) are powerful enough to classify accurately samples that can belong to 32-different types of cancer.

January 20, 2017

Scientists from the Sidney Kimmel Cancer Center at Thomas Jefferson University have pinpointed a survival protein for patients suffering from non-Hodgkin's lymphoma.

December 07, 2016

Scientists at the Sidney Kimmel Cancer Center have been able to validate the contemporary five-tiered Gleason Grade Grouping Using Population-based Data.

November 11, 2015

A single molecule called DNA-PKcs may drive metastatic processes that turn cancer from a slowly growing, relatively benign disease to a killer.

January 09, 2015

For some insight on this discussion, OncLive sat down with prostate cancer expert and president-elect of SUO, Leonard G. Gomella, MD.

October 24, 2014

The 12-month countdown to the adoption of ICD-10 has begun. ICD-10 represents the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (usually referred to as "ICD"), now overseen by the World Health Organization (WHO).

July 11, 2014

Researchers at Thomas Jefferson University's Kimmel Cancer Center in Philadelphia have developed a model for establishing a comprehensive multidisciplinary geriatric oncology center to avoid the potential overtreatment or undertreatment that elderly patients with cancer may face.

June 19, 2014

An MRI-guided focused ultrasound approach using heat to alleviate the pain commonly associated with bone metastases has proven to be safe and effective in a multi-center phase III clinical trial, yielding a 64% response rate.

May 16, 2014

Researchers at Thomas Jefferson University's Kimmel Cancer Center have developed a model for the establishment of a comprehensive multidisciplinary geriatric oncology center to help combat the over or under treatment that elderly oncology patients often face.

March 03, 2014

An immunotherapy drug for the treatment of prostate cancer, approved in the US in 2010, will soon be available in Europe.

January 17, 2014

The renaissance in immunology is already affecting treatment paradigms for a variety of gynecologic cancers, and the impact is only likely to expand.

November 27, 2013

William Kevin Kelly, DO, professor of medical oncology and urology, Thomas Jefferson University, discusses the possibility of preselecting which castration-resistant prostate cancer (CRPC) patients will be sensitive to chemotherapy or hormone therapy.

October 22, 2013

Russell J. Schilder, MD, director, Gynecologic Medical Oncology, Thomas Jefferson University, Kimmel Cancer Center, discusses PARP inhibitors and their potential role in gynecologic cancers.

September 23, 2013

Edith Mitchell, MD, FACP, clinical professor, director, Center to Eliminate Cancer Disparities Program Leader, Thomas Jefferson University, discusses an analysis of the VELOUR trial.

September 10, 2013

Edith Mitchell, MD, FACP, clinical professor, director, Center to Eliminate Cancer Disparities Program Leader, Thomas Jefferson University, talks about the growing number of drugs and regimens for patients with colorectal cancer.

May 31, 2013

Leonard G. Gomella, MD, chair of Urology at Thomas Jefferson University Hospital and Director of Clinical Affairs at the Kimmel Cancer Center, discusses the debate surrounding PSA-based screening in prostate cancer in 2013.